July 8, 2016

The Direction of Pharma/CRO Relationships


All life sciences companies struggle with developing internal capabilities and infrastructure for proactively managing their outsourced development partners and programs. As the dynamics of clinical development increase the complexity of research and development, companies are moving toward outsourcing various components of a drug’s development program to aid in balancing workloads.

With this increased level of outsourcing, there is a need for sponsors to figure out the best way to improve and manage working relationships with contract research organizations (CROs)

Fill out the form below to get our white paper.

[Form id="19"]